Ifosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known whether ifosfamide or doxorubicin is more
effective for advanced or metastatic soft tissue sarcoma.
PURPOSE: Randomized phase III trial to compare the effectiveness of ifosfamide with that of
doxorubicin in treating patients who have advanced or metastatic soft tissue sarcoma.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC